Clinical Trial Update: A Study of Sotorasib in People With Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This clinical trial update reports that a Phase 2 study of sotorasib for non-small cell lung cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• LUMAKRAS (sotorasib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Non Small Lung Cancer | Phase 2 | Status: RECRUITING